M. Cesana

422 total citations
28 papers, 332 citations indexed

About

M. Cesana is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, M. Cesana has authored 28 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 14 papers in Epidemiology and 8 papers in Molecular Medicine. Recurrent topics in M. Cesana's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (6 papers). M. Cesana is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (6 papers). M. Cesana collaborates with scholars based in Italy, Czechia and Canada. M. Cesana's co-authors include C. Mandelli, Bruno P. Imbimbo, D. Conte, Clementina Cocuzza, R. Mattina, G Broccali, Giovanni Bonfiglio, A Jardin, Francesca Crema and S. Ortolani and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and Journal of Hepatology.

In The Last Decade

M. Cesana

28 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Cesana Italy	12	121	109	76	63	49	28	332
Rudolf Schwabe Germany	11	57 0.5×	144 1.3×	79 1.0×	22 0.3×	20 0.4×	22	362
M. Levacher France	12	159 1.3×	50 0.5×	18 0.2×	17 0.3×	8 0.2×	25	655
F. Chast France	14	98 0.8×	29 0.3×	22 0.3×	15 0.2×	50 1.0×	38	550
Ronilda D’Cunha United States	10	56 0.5×	67 0.6×	34 0.4×	23 0.4×	19 0.4×	27	338
Harold Gaya United Kingdom	8	98 0.8×	51 0.5×	24 0.3×	18 0.3×	33 0.7×	13	368
D. H. Staniforth United Kingdom	12	48 0.4×	61 0.6×	54 0.7×	7 0.1×	27 0.6×	18	339
Kaushal K Prasad India	14	133 1.1×	14 0.1×	80 1.1×	48 0.8×	8 0.2×	38	558
B. Lank Canada	9	166 1.4×	89 0.8×	23 0.3×	6 0.1×	92 1.9×	13	419
Joan Antoni Schoenenberger-Arnaiz Spain	13	146 1.2×	45 0.4×	29 0.4×	5 0.1×	23 0.5×	33	485
S. C. Schimpff United States	11	131 1.1×	167 1.5×	38 0.5×	16 0.3×	124 2.5×	18	498

Countries citing papers authored by M. Cesana

Since Specialization

Citations

This map shows the geographic impact of M. Cesana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cesana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cesana more than expected).

Fields of papers citing papers by M. Cesana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cesana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cesana. The network helps show where M. Cesana may publish in the future.

Co-authorship network of co-authors of M. Cesana

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cesana. A scholar is included among the top collaborators of M. Cesana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cesana. M. Cesana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kinzig‐Schippers, Martina, Uwe Fuhr, M. Cesana, et al.. (1998). Absence of Effect of Rufloxacin on Theophylline Pharmacokinetics in Steady State. Antimicrobial Agents and Chemotherapy. 42(9). 2359–2364. 3 indexed citations

Imbimbo, Bruno P., et al.. (1997). Population pharmacokinetics of rufloxacin in patients with acute exacerbations of chronic bronchitis. European Journal of Pharmaceutical Sciences. 5(1). 37–42. 1 indexed citations

Gasbarrini, Antonio, Nicola Gentiloni, Cristiana Di Campli, et al.. (1997). Acute liver injury related to the use of niperotidine. Journal of Hepatology. 27(3). 583–586. 9 indexed citations

Gismondo, Maria Rita, et al.. (1995). Impact of Rufloxacin and Ciprofloxacin on the Intestinal Microflora in a Germ-Free Mice Model. Chemotherapy. 41(4). 281–288. 10 indexed citations

Cesana, M., et al.. (1995). 5-Day Rufloxacin Treatment Versus 7-Day Ciprofloxacin Treatment in Patients with Acute Exacerbations of Chronic Bronchitis. Clinical Drug Investigation. 9(6). 334–343. 6 indexed citations

Bach, D., et al.. (1995). Rufloxacin Once Daily Versus Ciprofloxacin Twice Daily in the Treatment of Patients with Acute Uncomplicated Pyelonephritis. The Journal of Urology. 154(1). 19–24. 16 indexed citations

Furneri, Pio Maria, et al.. (1994). In vitro Activity of Rufloxacin against <i>Listeria monocytogenes</i>, <i>Legionella pneumophila</i>, and Chlamydia trachomatis. Chemotherapy. 40(2). 104–108. 5 indexed citations

Arena, Adriana, et al.. (1993). Cellular uptake and activity of rufloxacin in different cell types and professional phagocytic cells. International Journal of Antimicrobial Agents. 2(2). 111–116. 1 indexed citations

Mattina, R., et al.. (1993). Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Infection. 21(2). 106–111. 16 indexed citations

10.

Privitera, Gaetano Pierpaolo, Bruno P. Imbimbo, M. Cesana, et al.. (1993). Biliary excretion of rufloxacin in humans. Antimicrobial Agents and Chemotherapy. 37(12). 2545–2549. 3 indexed citations

11.

Ravizzola, G, et al.. (1992). Antibacterial activity of rufloxacin in theStaphylococcus aureus rat granuloma pouch model. Current Microbiology. 24(6). 349–353. 7 indexed citations

12.

Cesana, M., G Broccali, Bruno P. Imbimbo, & A. Crema. (1991). Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.. PubMed. 29(4). 133–8. 6 indexed citations

13.

Mattina, R., Clementina Cocuzza, M. Cesana, & Giovanni Bonfiglio. (1991). In vitro Activity of a New Quinolone, Rufloxacin, against Nosocomial Isolates. Chemotherapy. 37(4). 260–269. 21 indexed citations

14.

Mattina, R., et al.. (1991). Pharmacokinetics of Rufloxacin in Healthy Volunteers after Repeated Oral Doses. Chemotherapy. 37(6). 389–397. 18 indexed citations

15.

Piperno, Alberto, Dario Conte, C. Mandelli, et al.. (1989). HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives. Tissue Antigens. 33(4). 431–436. 11 indexed citations

16.

Conte, D., et al.. (1989). Effectiveness of Erythrocytapheresis in Idiopathic Hemochromatosis. Report of 14 Cases. The International Journal of Artificial Organs. 12(1). 59–62. 19 indexed citations

17.

Conte, D., et al.. (1989). Bone involvement in primary hemochromatosis and alcoholic cirrhosis.. PubMed. 84(10). 1231–4. 38 indexed citations

18.

Mandelli, C., M. Cesana, P. Ferroni, et al.. (1988). HBV, HDV and HIV infections in 242 drug addicts: Two-year follow-up. European Journal of Epidemiology. 4(3). 318–321. 8 indexed citations

19.

Conte, D., P. Velio, C. Mandelli, et al.. (1987). Stainable iron in gastric and duodenal mucosa of primary hemochromatosis patients and alcoholics.. PubMed. 82(3). 237–40. 12 indexed citations

20.

Conte, Dario, Alberto Piperno, C. Mandelli, et al.. (1986). Clinical, biochemical and histological features of primary haemochromatosis: a report of 67 cases. Liver International. 6(5). 310–315. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact